Performance analysis of Evommune (EVMN)
Annual Return
Since Nov 6, 2025, EVMN has had an average annual return of -55.14%, underperforming the benchmark SPY, which returned +16.98% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.66% | -15.37% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.72% | +43.65% | -11.58% | +3.53% | -2.40% | -42.79% | -13.24% | -32.66% | |||||
| 2025 | +2.37% | -17.33% | -15.37% |
Drawdown analysis of Evommune (EVMN)
The maximum drawdown for the EVMN was -63.48%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current EVMN drawdown is -63.48%.
Since Nov 6, 2025 EVMN has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -63.48% | Feb 13, 2026 | 106 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |
| -31.55% | Dec 4, 2025 | 10 | Dec 18, 2025 | 35 | Feb 10, 2026 | 45 |
| -9.94% | Nov 6, 2025 | 5 | Nov 13, 2025 | 10 | Nov 28, 2025 | 15 |
| -3.96% | Feb 10, 2026 | 2 | Feb 12, 2026 | 1 | Feb 13, 2026 | 3 |